Q. Reynaud

发表

A New Pathogenic Missense Variant in a Consanguineous North-African Family Responsible for a Highly Variable Aceruloplasminemia Phenotype: A Case-Report

S. Mainbourg, H. Lobbes, Q. Reynaud, 2022, Frontiers in Neuroscience.

HOMA indices as screening tests for cystic fibrosis-related diabetes.

P. Reix, I. Pin, I. Durieu, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France.

I. Durieu, M. Rabilloud, Q. Reynaud, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis.

V. Cottin, I. Durieu, S. Provencher, 2019, Autoimmunity reviews.

High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.

G. Lina, P. Reix, I. Durieu, 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura

I. Durieu, J. Lega, Q. Reynaud, 2017, Medicine.

Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis.

S. Laporte, C. Chapelle, J. Lega, 2014, Autoimmunity reviews.

Quantifying Long-term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis.

I. Durieu, M. Rabilloud, S. Touzet, 2020, Annals of the American Thoracic Society.

Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey

S. Vukusic, V. Cottin, I. Durieu, 2017, PloS one.

Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases

I. Durieu, J. Lega, Q. Reynaud, 2018, Lupus.

Collaborative research protocol to define patient-reported experience measures of the cystic fibrosis care pathway in France: the ExPaParM study

P. Lombrail, J. Haesebaert, C. Llerena, 2021, Orphanet Journal of Rare Diseases.

Aminoglycoside exposure and renal function before lung transplantation in adult cystic fibrosis patients

I. Durieu, D. Fouque, S. Pelletier, 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis.

I. Ray-Coquard, I. Durieu, C. Rousset-Jablonski, 2018, European journal of obstetrics, gynecology, and reproductive biology.

Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data

Samuel S Allemann, P. Reix, I. Durieu, 2019, Patient preference and adherence.

PPA_A_211769 1497..1510

Samuel S Allemann, P. Reix, I. Durieu, 2019 .

[Review of the current use of rituximab during 4 years in a French university hospital].

M. Killian, J. Camdessanché, Q. Reynaud, 2015, La Revue de medecine interne.

Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta‐analysis

P. Reix, P. Burgel, I. Durieu, 2020, Pediatric pulmonology.

The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.

V. Cottin, I. Durieu, J. Lega, 2014, Autoimmunity reviews.

Idiopathic inflammatory myopathies and the lung

V. Cottin, I. Durieu, A. Belot, 2015, European Respiratory Review.

Impact of 1h oral glucose tolerance test on the clinical status of adult cystic fibrosis patients over a 4-year period

R. Rabasa-Lhoret, I. Durieu, S. Touzet, 2021, PloS one.

Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis

P. Reix, P. Burgel, C. Marguet, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long‐term extrapulmonary comorbidities after lung transplantation in cystic fibrosis: Update of specificities

I. Durieu, Q. Reynaud, S. Jardel, 2018, Clinical transplantation.

178 Glucose tolerance in cystic fibrosis patients over a 3-year period (DIAMUCO study)

P. Reix, I. Pin, M. Laville, 2015 .

Late Stenotrophomonas maltophilia pacemaker infective endocarditis.

F. Lucht, F. Suy, C. Roméyer-Bouchard, 2015, Medecine et maladies infectieuses.

Reproductive health after thoracic transplantation: An ISHLT expert consensus statement.

M. Walsh, H. Ross, M. Kittleson, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Extra-respiratory comorbidities and transplantation in the French cystic fibrosis registry

I. Durieu, S. Mainbourg, Q. Reynaud, 2019, Expert review of respiratory medicine.

Iron Deficiency in Cystic Fibrosis: A Cross-Sectional Single-Centre Study in a Referral Adult Centre

I. Durieu, S. Mainbourg, H. Lobbes, 2022, Nutrients.

Idiopathic inflammatory myopathies and the lung

V. Cottin, I. Durieu, A. Belot, 2015, European Respiratory Review.

Combined indeterminate and impaired glucose tolerance is a novel group at high risk of Cystic Fibrosis-related Diabetes.

R. Rabasa-Lhoret, I. Durieu, P. Senior, 2021, The Journal of clinical endocrinology and metabolism.

Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.

D. Caimmi, A. Didier, S. Leroy, 2020, American journal of respiratory and critical care medicine.

Retrospective observational study of French patients with cystic fibrosis and a Gly551Asp-CFTR mutation after 1 and 2years of treatment with ivacaftor in a real-world setting.

A. Munck, L. Mély, V. David, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers

P. Burgel, L. Mély, L. Kessler, 2022, Journal of clinical & translational endocrinology.

Improvement in contraceptive coverage and gynecological care of adult women with cystic fibrosis following the implementation of an on-site gynecological consultation.

I. Ray-Coquard, I. Durieu, C. Rousset-Jablonski, 2019, Contraception.

Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies.

D. Vital-Durand, I. Durieu, J. Lega, 2015, Autoimmunity reviews.

Bifidobacterium species bacteremia: risk factors in adults and infants.

F. Suy, E. Botelho-Nevers, A. Gagneux-Brunon, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Contraceptive practices and cervical screening in women with cystic fibrosis.

I. Durieu, J. Lega, Q. Reynaud, 2015, Human reproduction.

A formalized transition program for cystic fibrosis: A 10‐year retrospective analysis of 97 patients in Lyon

P. Reix, I. Durieu, Q. Reynaud, 2021, Pediatric pulmonology.

Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient

I. Durieu, F. Persat, D. Grenet, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Elevated IgG4 serum levels in patients with cystic fibrosis

I. Durieu, J. Lega, Q. Reynaud, 2017, PloS one.

Temporal trends in healthcare resource use and associated costs of patients with cystic fibrosis.

I. Durieu, E. van Ganse, M. Belhassen, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function.

I. Durieu, M. Rabilloud, S. Touzet, 2018, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients.

I. Durieu, L. Kessler, S. Touzet, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Pregnancy outcome in women with cystic fibrosis‐related diabetes

I. Durieu, M. Rabilloud, S. Touzet, 2017, Acta obstetricia et gynecologica Scandinavica.

Cancer incidence and prevalence in cystic fibrosis patients with and without a lung transplant in France

I. Durieu, C. Rousset-Jablonski, E. van Ganse, 2022, Frontiers in Public Health.

Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: A meta-analysis.

I. Durieu, A. Belot, J. Lega, 2020, Autoimmunity reviews.

Pregnancy outcome in women with cystic fibrosis and poor pulmonary function

I. Durieu, S. Touzet, Q. Reynaud, 2018, Revue d'épidémiologie et de santé publique.

Acute renal and splenic infarctions: a review.

I. Durieu, L. Juillard, D. Fouque, 2019, QJM : monthly journal of the Association of Physicians.

Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases

A. Belot, P. Sève, Q. Reynaud, 2022, Journal of clinical medicine.

Glycated Hemoglobin as a First-line Screening Test for Cystic Fibrosis‒Related Diabetes and Impaired Glucose Tolerance in Children With Cystic Fibrosis: A Validation Study.

Q. Reynaud, G. Mailhot, Azadeh Shohoudi, 2021, Canadian journal of diabetes.

Screening for Cystic Fibrosis-Related Diabetes: Matching Pathophysiology and Addressing Current Challenges.

I. Durieu, Q. Reynaud, A. Coriati, 2016, Canadian journal of diabetes.

Prevalence of Giant Cell Arteritis Relapse in Patients Treated With Glucocorticoids: A Meta‐Analysis

I. Durieu, F. Gueyffier, M. Cucherat, 2020, Arthritis care & research.

Possible COVID-19 recurrence in an older patient: a case report

C. Falandry, A. Garnier-Crussard, Q. Reynaud, 2020 .

A conceptual framework to develop a patient-reported experience questionnaire on the cystic fibrosis journey in France: the ExPaParM collaborative study

P. Lombrail, J. Haesebaert, C. Llerena, 2023, Orphanet Journal of Rare Diseases.

[Tryptase: A practical guide for the physician].

I. Durieu, J. Lega, S. Mainbourg, 2020, La Revue de medecine interne.

Human papillomavirus prevalence, persistence and cervical dysplasia in females with cystic fibrosis.

I. Ray-Coquard, I. Durieu, C. Rousset-Jablonski, 2022, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Acute kidney injury, a rare complication of acute hepatitis E infection.

I. Durieu, Q. Reynaud, S. Durupt, 2017, Medecine et maladies infectieuses.

Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.

P. Reix, P. Burgel, N. Stremler, 2023, Diabetes & metabolism.

Cystic fibrosis‐related diabetes before lung transplantation is associated with lower survival but does not affect long‐term renal function

I. Durieu, S. Touzet, S. Mainbourg, 2019, Pediatric pulmonology.

Glucose tolerance in Canadian and French cystic fibrosis adult patients

I. Durieu, E. Blond, Y. Berthiaume, 2019, Scientific Reports.

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis

P. Reix, I. Durieu, S. Goutelle, 2022, Pharmaceutics.

An uncommon case of post partum seizures.

M. Killian, B. Tardy, Q. Reynaud, 2015, European journal of internal medicine.

A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit

I. Durieu, H. Rouzé, S. Touzet, 2023, Patient preference and adherence.

Long‐term extrapulmonary comorbidities after lung transplantation in cystic fibrosis: Update of specificities

I. Durieu, Q. Reynaud, S. Jardel, 2018, Clinical transplantation.

[Gynecological management and follow-up in women with cystic fibrosis].

C. Rousset-Jablonski, Q. Reynaud, S. Durupt, 2018, Revue des maladies respiratoires.

[Tryptase: A practical guide for the physician].

I. Durieu, J. Lega, J. Lega, 2020, La Revue de medecine interne.